# LRP
references
Reference list
[1] S. K. Doke and S. C. Dhawale, “Alternatives to animal testing: A review,” Saudi Pharmaceutical Journal, vol. 23, no. 3, pp. 223–229, Jul. 2015, doi: 10.1016/j.jsps.2013.11.002. 

[2]J.-A. McArthur, “Taking Suffering Out of Science,” The Humane Society of the United States, 2000. https://www.humanesociety.org/all-our-fights/taking-suffering-out-science 

[3]“Why We Should Be Interested in Human Tissue Chips | 3D Cell Culture | Corning,” www.corning.com.https://www.corning.com/worldwide/en/products/life-sciences/resources/stories/the-cutting-edge/why-we-should-be-interested-in-human-tissue-chips.html  (accessed Oct. 17, 2022).

[4] C. Ma, Y. Peng, H. Li, and W. Chen, “Organ-on-a-Chip: A New Paradigm for Drug Development,” Trends in Pharmacological Sciences, vol. 42, no. 2, pp. 119–133, Feb. 2021, doi: 10.1016/j.tips.2020.11.009.  
[5] Yang Q;Xiao Z;Lv X;Zhang T;Liu H; “Fabrication and biomedical applications of heart-on-a-chip,” International journal of bioprinting. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/34286153/ . [Accessed: 11-Oct-2022].
[6]Zhang, Y.S. et al. (2016) “Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip,” Biomaterials, 110, pp. 45–59. Available at: https://doi.org/10.1016/j.biomaterials.2016.09.003.
[7]Mathur, A., Loskill, P., Shao, K. et al. Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications. Sci Rep 5, 8883 (2015). https://doi.org/10.1038/srep08883 
[8] Mittal, R, Woo, FW, Castro, CS, et al. Organ-on-chip models: Implications in drug discovery and clinical applications. J Cell Physiol. 2019; 234: 8352– 8380. https://doi.org/10.1002/jcp.27729

[9] S. P. Sheehy, A. Grosberg, P. Qin, D. J. Behm, J. P. Ferrier, M. A. Eagleson, A. P. Nesmith, D. Krull, J. G. Falls, P. H. Campbell, M. L. McCain, R. N. Willette, E. Hu, and K. K. Parker, “Toward improved myocardial maturity in an organ-on-chip platform with immature cardiac myocytes,” Experimental Biology and Medicine, vol. 242, no. 17, pp. 1643–1656, 2017. 
[10] D. Papadimitriou , I. Dontas, and T. Xanthos , “The use of mice and rats as animal models for cardiopulmonary resuscitation research,” Laboratory animals, 2008. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/18625581/. [Accessed: 20-Oct-2022].
[11] E. L. Vegter, E. S. Ovchinnikova, H. H. W. Silljé, L. M. G. Meems, A. van der Pol, A. R. van der Velde, E. Berezikov, A. A. Voors, R. A. de Boer, and P. van der Meer, “Rodent heart failure models do not reflect the human circulating microrna signature in heart failure,” PloS one, 05-May-2017. [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5419653/. [Accessed: 20-Oct-2022].
[12] A. J. Clippinger et al., “Alternative approaches for acute inhalation toxicity testing to address global regulatory and non-regulatory data requirements: An international workshop report,” Toxicology in Vitro, vol. 48, pp. 53–70, Apr. 2018, doi: 10.1016/j.tiv.2017.12.011.

[13] K.-C. . Lin, C.-Z. . Yen, J.-W. . Yang, J. H. Y. Chung, and G.-Y. . Chen, “Airborne toxicological assessment: The potential of lung-on-a-chip as an alternative to animal testing,” Materials Today Advances, vol. 14, p. 100216, Jun. 2022, doi: 10.1016/j.mtadv.2022.100216.

[14] J. Seo and D. Huh, “Chapter 7 - Microphysiological models of human organs: A case study on microengineered lung-on-a-chip systems,” ScienceDirect, Jan. 01, 2019. https://www.sciencedirect.com/science/article/pii/B9780128136713000074  (accessed Oct. 16, 2022).

[15] Z. Nova, H. Skovierova, and A. Calkovska, “Alveolar-Capillary Membrane-Related Pulmonary Cells as a Target in Endotoxin-Induced Acute Lung Injury,” International Journal of Molecular Sciences, vol. 20, no. 4, p. 831, Jan. 2019, doi: 10.3390/ijms20040831.

[16] Z. Li, J. Hui, P. Yang, and H. Mao, “Microfluidic Organ-on-a-Chip System for Disease Modeling and Drug Development,” Biosensors, vol. 12, no. 6, p. 370, May 2022, doi: 10.3390/bios12060370.

[17] H. Kimura, Y. Sakai, and T. Fujii, “Organ/body-on-a-chip based on microfluidic technology for drug discovery,” Drug Metabolism and Pharmacokinetics, vol. 33, no. 1, pp. 43–48, Feb. 2018, doi: 10.1016/j.dmpk.2017.11.003. 
